{
    "results": [
        {
            "acronym": "BANN", 
            "arm_group": [
                {
                    "arm_group_label": "Group A", 
                    "arm_group_type": null, 
                    "description": "Patients with clear cell renal cell carcinoma with metastases."
                }, 
                {
                    "arm_group_label": "Group B", 
                    "arm_group_type": null, 
                    "description": "Patients with low grade neuro-endocrine tumours with metastases."
                }
            ], 
            "biospec_descr": {
                "textblock": "2 x 10mL whole blood, stored as platelet rich and platelet poor plasma."
            }, 
            "biospec_retention": "Samples With DNA", 
            "brief_summary": {
                "textblock": "The primary objective of this study is to analyse the concentration dopamine and serotonin\n      in thrombocytes of patients with renal cell carcinoma and neuro-endocrine tumours compared\n      to the concentrations of these catecholamines in healthy volunteers. The concentration\n      dopamine and serotonin in thrombocytes with and without medication will also be evaluated."
            }, 
            "brief_title": "Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.", 
            "clinical_results": {}, 
            "completion_date": {
                "attributes": {
                    "type": "Actual"
                }, 
                "value": "April 2012"
            }, 
            "condition": [
                "Carcinoma", 
                "Carcinoma, Renal Cell", 
                "Neuroendocrine Tumors", 
                "Carcinoid Tumor", 
                "Pancreatic Islet Cell Tumors"
            ], 
            "condition_browse": {
                "mesh_term": [
                    "Carcinoid Tumor", 
                    "Carcinoma", 
                    "Carcinoma, Renal Cell", 
                    "Endocrine Gland Neoplasms", 
                    "Neuroendocrine Tumors", 
                    "Adenoma, Islet Cell"
                ]
            }, 
            "detailed_description": {
                "textblock": "-  To analyse the concentration catecholamines in thrombocytes of patients with clear cell\n           renal cell carcinoma and low grade neuroendocrine tumours.\n\n        -  To compare these concentrations with the concentrations catecholamines in thrombocytes\n           of healthy controls.\n\n        -  To analyse the concentration catecholamines in thrombocytes of patients with clear cell\n           renal cell carcinoma and patients with low grade neuroendocrine tumours with and\n           without medication."
            }, 
            "eligibility": {
                "criteria": {
                    "textblock": "Inclusion Criteria:\n\n          -  Age 18 years old or older.\n\n          -  Patients with clear cell renal cell carcinoma with metastases or patients with a\n             low-grade neuro-endocrine tumor with metastases.\n\n          -  Written informed consent\n\n        Exclusion Criteria:\n\n          -  Use of L-dopa or SSRI.\n\n          -  Patients with a second primary malignancy."
                }, 
                "gender": "Both", 
                "healthy_volunteers": "No", 
                "maximum_age": "N/A", 
                "minimum_age": "18 Years", 
                "sampling_method": "Probability Sample", 
                "study_pop": {
                    "textblock": "Patients with clear cell renal cell carcinoma with metastases and patients with low grade\n        neuroendocrine tumours with metastases."
                }
            }, 
            "end_date": {}, 
            "enrollment": {
                "attributes": {
                    "type": "Actual"
                }, 
                "value": "40"
            }, 
            "firstreceived_date": {
                "attributes": {
                    "type": null
                }, 
                "value": "July 19, 2011"
            }, 
            "firstreceived_results_date": {}, 
            "has_expanded_access": "No", 
            "id": "NCT01398306", 
            "id_info": {
                "nct_alias": [], 
                "nct_id": "NCT01398306", 
                "org_study_id": "230520112", 
                "secondary_id": []
            }, 
            "intervention": [
                {
                    "arm_group_label": [
                        "Group A", 
                        "Group B"
                    ], 
                    "description": "We obtain 10mL blood of the patients. The blood is obtained twice: once with angiogenesis inhibitors or mTOR inhibitors, and once without.", 
                    "intervention_name": "Blood sampling by vena punction.", 
                    "intervention_type": "Other", 
                    "other_name": []
                }
            ], 
            "intervention_browse": {
                "mesh_term": [
                    "Angiogenesis Inducing Agents", 
                    "Angiogenesis Inhibitors"
                ]
            }, 
            "is_fda_regulated": "No", 
            "is_section_801": null, 
            "keyword": [
                "Angiogenesis Inhibitors", 
                "Neoplasms, Glandular and Epithelial", 
                "Neoplasms by Histologic Type", 
                "Neoplasms", 
                "Adenocarcinoma", 
                "Kidney Neoplasms", 
                "Urologic Neoplasms", 
                "Urogenital Neoplasms", 
                "Neoplasms by Site", 
                "Kidney Diseases", 
                "Angiogenesis Inducing Agents", 
                "Biological Markers"
            ], 
            "last_injected": "2014-04-18T03:21:16.632Z", 
            "lastchanged_date": {
                "attributes": {
                    "type": null
                }, 
                "value": "May 7, 2012"
            }, 
            "link": [], 
            "location": [
                {
                    "contact": {}, 
                    "contact_backup": {}, 
                    "facility": {
                        "address": {
                            "city": "Groningen", 
                            "country": "Netherlands", 
                            "state": null, 
                            "zip": "9700RB"
                        }, 
                        "name": "University Medical Center Groningen"
                    }, 
                    "geodata": {
                        "formatted": "Groningen, The Netherlands", 
                        "latitude": 53.219, 
                        "longitude": 6.567, 
                        "original": "Groningen, Netherlands"
                    }, 
                    "investigator": [], 
                    "status": null
                }
            ], 
            "location_countries": {
                "country": [
                    "Netherlands"
                ]
            }, 
            "number_of_arms": null, 
            "number_of_groups": "2", 
            "official_title": "Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.", 
            "other_outcome": [], 
            "overall_contact": {}, 
            "overall_contact_backup": {}, 
            "overall_official": [
                {
                    "affiliation": "University Medical Centre Groningen", 
                    "degrees": null, 
                    "first_name": null, 
                    "last_name": "Sjoukje F. Oosting, MD", 
                    "middle_name": null, 
                    "role": "Study Chair"
                }, 
                {
                    "affiliation": "University Medical Centre Groningen", 
                    "degrees": null, 
                    "first_name": null, 
                    "last_name": "Marloes A.M. Peters", 
                    "middle_name": null, 
                    "role": "Principal Investigator"
                }
            ], 
            "overall_status": "Completed", 
            "oversight_info": {
                "authority": [
                    "The Netherlands: Medical Ethics Review Committee (METC)"
                ], 
                "has_dmc": "No"
            }, 
            "phase": "N/A", 
            "primary_completion_date": {
                "attributes": {
                    "type": "Actual"
                }, 
                "value": "April 2012"
            }, 
            "primary_outcome": [
                {
                    "description": null, 
                    "measure": "Difference in concentrations DA and 5-HT in thrombocytes of patients with clear cell renal cell carcinoma and healthy controls, and patients with low grade neuroendocrine tumours and healthy controls.", 
                    "safety_issue": "No", 
                    "time_frame": "one year"
                }
            ], 
            "reference": [], 
            "removed_countries": {}, 
            "required_header": {
                "link_text": "Link to the current ClinicalTrials.gov record.", 
                "url": "http://clinicaltrials.gov/show/NCT01398306"
            }, 
            "responsible_party": {
                "investigator_affiliation": "University Medical Centre Groningen", 
                "investigator_full_name": "S.F. Oosting", 
                "investigator_title": "Principal Investigator", 
                "name_title": null, 
                "organization": null, 
                "responsible_party_type": "Principal Investigator"
            }, 
            "results_reference": [], 
            "secondary_outcome": [
                {
                    "description": null, 
                    "measure": "Difference in concentrations DA and 5-HT in thrombocytes of patients with clear cell renal cell carcinoma and low grade neuroendocrine tumours with and without medication.", 
                    "safety_issue": "No", 
                    "time_frame": "one year"
                }
            ], 
            "source": "University Medical Centre Groningen", 
            "sponsors": {
                "collaborator": [], 
                "lead_sponsor": {
                    "agency": "University Medical Centre Groningen", 
                    "agency_class": "Other"
                }
            }, 
            "start_date": {
                "attributes": {
                    "type": null
                }, 
                "value": "July 2011"
            }, 
            "study_design": "Observational Model: Cohort, Time Perspective: Cross-Sectional", 
            "study_type": "Observational", 
            "target_duration": null, 
            "verification_date": {
                "attributes": {
                    "type": null
                }, 
                "value": "May 2012"
            }, 
            "why_stopped": null
        }
    ]
}